Calidi Biotherapeutics Inc. Common Stock (CLDI)
Stock · AMEX · Health Care
$0.79as of 10/16/2026
Price chart
Active signals
CLDI Signal Track Record
How signals performed across all stocks →What CLDI's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band BreakdownActive now | 25 | -20.8% | 28% | September 14, 2026 |
| Bollinger Band Breakout | 14 | -1.1% | 36% | July 9, 2025 |
| Volume Spike | 13 | -18.9% | 8% | September 23, 2026 |
| 200-Day Moving Average TouchActive now | 4 | +0.1% | 50% | August 21, 2023 |
| Any 20-session window (baseline) | -12.0% | 32% |
Computed by MarketWall from daily closing prices since August 17, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CLDI
Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck c…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 29
- Website
- www.calidibio.com/
Fundamentals
- 1-day range
- $0.8566$0.8899
- Market cap
- $4.38M
- P/E (trailing)
- —
- P/E (forward)
- -0.98
- EPS (trailing)
- $-63.54
- Dividend yield
- —
- Beta
- 1.38
- Avg. volume
- 250.1K
Calidi Biotherapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- CLDICalidi Biotherapeutics Inc. Common Stock$0.837▼ 3.79%Market cap $4.38MP/E —$0.82$27.84
- BCABBioAtla Inc. Common Stock$1.36▲ 4.62%Market cap $5.53MP/E —$1.07$71.5
- VIVSVivoSim Labs Inc. Common Stock$0.16▼ 5.88%Market cap $5.53MP/E —$0.1495$3.4
- PMCBPharmaCyte Biotech Inc. Common Stock$0.3402▼ 4.81%Market cap $6.34MP/E —$0.3339$1.51
- LIMNLiminatus Pharma Inc. Class A Common Stock$3.04▼ 5.30%Market cap $6.64MP/E —$3.25$141.5
- SLXNSilexion Therapeutics Corp Ordinary Shares$0.153▼ 19.05%Market cap $1.90MP/E —$0.2362$42.6
- SCNIScinai Immunotherapeutics Ltd. American Depositary Shares$0.752▼ 16.63%Market cap $1.30MP/E 0.16$0.75$15.65
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CLDI Calidi Biotherapeutics Inc. Common Stock | $4.38M | — | $0.837 | ▼ 3.79% | $0.82$27.84 |
| BCAB BioAtla Inc. Common Stock | $5.53M | — | $1.36 | ▲ 4.62% | $1.07$71.5 |
| VIVS VivoSim Labs Inc. Common Stock | $5.53M | — | $0.16 | ▼ 5.88% | $0.1495$3.4 |
| PMCB PharmaCyte Biotech Inc. Common Stock | $6.34M | — | $0.3402 | ▼ 4.81% | $0.3339$1.51 |
| LIMN Liminatus Pharma Inc. Class A Common Stock | $6.64M | — | $3.04 | ▼ 5.30% | $3.25$141.5 |
| SLXN Silexion Therapeutics Corp Ordinary Shares | $1.90M | — | $0.153 | ▼ 19.05% | $0.2362$42.6 |
| SCNI Scinai Immunotherapeutics Ltd. American Depositary Shares | $1.30M | 0.16 | $0.752 | ▼ 16.63% | $0.75$15.65 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga · 10/6/2026
- Calidi Biotherapeutics Receives NYSE American Non-Compliance Noticebenzinga · 9/25/2026
- Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity DeficiencyYahoo · 9/25/2026
- Calidi Biotherapeutics Receives NYSE American Non-Compliance NoticeBenzinga · 9/25/2026
- Calidi Biotherapeutics Announces $1.2 Million Registered Direct OfferingYahoo · 9/17/2026
- Calidi Biotherapeutics Announces Registered Direct Offering 1,025,640 Shares At $1.17 Per ShareBenzinga · 9/17/2026
Insider Activity
Insider Actions →- Scott Leftwich · August 17, 2026 · Grant4.0K
- Fernandez Santidrian Antonio · August 17, 2026 · Grant16.0K
- Corazon (Corsee) D. Sanders · August 17, 2026 · Grant6.0K
- Alan R. Stewart · August 17, 2026 · Grant4.0K
- Andrew C. Jackson · August 17, 2026 · Grant14.0K
- Peoples George · August 17, 2026 · Grant4.0K
- James A. Schoeneck · August 17, 2026 · Grant5.0K
- Eric E. Poma · August 17, 2026 · Grant32.0K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
CLDI Included in After-Market Movers List
Calidi Biotherapeutics was listed among 12 health care stocks moving in Tuesday's after-market session. The stock is currently trading near its 52-week low of $1.03, reflecting significant volatility. This inclusion highlights recent price action in the biotech sector.
CLDI Included in After-Market Movers List. Calidi Biotherapeutics was listed among 12 health care stocks moving in Tuesday's after-market session. The stock is currently trading near its 52-week low of $1.03, reflecting significant volatility. This inclusion highlights recent price action in the biotech sector.